John L. Magnani

CIK 1589713 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 9, 2014 · Latest: Jan. 9, 2014

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 11, 2022 CBIO P 45,045 $1.17 $52,703 366,078 Direct +14.03% Acquired -86.1% (price as of 2026-08-21)
March 9, 2022 CBIO S 3,227 $1.09 $3,517 321,033 Direct -1.00% Disposed -85.1% (price as of 2026-08-21)
Oct. 18, 2018 CBIO S 3,527 $14.02 $49,449 75,793 Direct -4.45% Disposed -98.8% (price as of 2026-08-21)
Oct. 17, 2018 CBIO S 7,273 $14.00 $101,822 79,320 Direct -8.40% Disposed -98.8% (price as of 2026-08-21)
Oct. 16, 2018 CBIO S 14,200 $14.01 $198,942 86,593 Direct -14.09% Disposed -98.8% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 21, 2022 CBIO Employee Stock Option (right to buy) Common Stock (25,000) $1.11 Jan. 20, 2032 25,000 Acquired
Jan. 21, 2022 CBIO Employee Stock Option (right to buy) Common Stock (100,000) $1.11 Jan. 20, 2032 100,000 Acquired
Jan. 20, 2021 CBIO Employee Stock Option (right to buy) Common Stock (69,000) $3.81 Jan. 19, 2031 69,000 Acquired
Jan. 22, 2020 CBIO Employee Stock Option (right to buy) Common Stock (120,000) $4.72 Jan. 21, 2030 120,000 Acquired
Jan. 6, 2020 CBIO Employee Stock Option (right to buy) Common Stock (106,983) $1.12 Jan. 4, 2021 106,983 Disposed
Dec. 20, 2019 CBIO Employee Stock Option (right to buy) Common Stock (106,984) $1.12 Jan. 4, 2021 106,984 Disposed
Jan. 17, 2019 CBIO Employee Stock Option (right to buy) Common Stock (100,000) $10.59 Jan. 16, 2029 100,000 Acquired
May 23, 2018 CBIO Warrant to Purchase Common Stock (right to buy) Common Stock (596) $0.33 Jan. 16, 2019 596 Disposed
May 23, 2018 CBIO Warrant to Purchase Common Stock (right to buy) Common Stock (895) $0.33 July 3, 2018 895 Disposed
Jan. 10, 2018 CBIO Employee Stock Option (right to buy) Common Stock (75,000) $20.03 Jan. 9, 2028 75,000 Acquired
May 10, 2017 CBIO Employee Stock Option (right to buy) Common Stock (8,928) $1.12 Jan. 4, 2021 8,928 Disposed
Jan. 4, 2017 CBIO Employee Stock Option (right to buy) Common Stock (75,000) $6.33 Jan. 3, 2027 75,000 Acquired
Jan. 7, 2016 CBIO Employee Stock Option (right to buy) Common Stock (71,000) $5.22 Jan. 6, 2026 71,000 Acquired
Jan. 8, 2015 CBIO Employee Stock Option (right to buy) Common Stock (71,000) $7.15 Jan. 7, 2025 71,000 Acquired
Jan. 15, 2014 CBIO Series A-1 Preferred Stock Common Stock (9,969) — — 32,918 Disposed
Jan. 9, 2014 CBIO Stock Option (right to buy) Common Stock (169,038) $8.00 Jan. 9, 2024 169,038 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 9, 2014 CBIO Common Stock 80,405 Direct
Jan. 9, 2014 CBIO Common Stock 4,845 Indirect
Jan. 9, 2014 CBIO Employee Stock Option (right to buy)→ Common Stock — Direct
Jan. 9, 2014 CBIO Series A-1 Preferred Stock→ Common Stock (9,969) 9,969 Direct
Jan. 9, 2014 CBIO Warrant to Purchase Common Stock (right to buy)→ Common Stock — Direct
Jan. 9, 2014 CBIO Warrant to Purchase Common Stock (right to buy)→ Common Stock — Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CBIO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2014 $309,836 — — — $81,375 — — $1,427,414

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.